-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: The third batch of national harvest, the whole information finishing collectionthe third batch of the country as expected to come, the third batch and the first two batch of what is different?specific content: the scope of the report is expanded, clinical use has requirements, catalog more clear, the volume catalog products / product regulations morecontent is a little bit, according to the timeline and event axis one by one finishing:timelinethe third batch of propulsion order
through the first batch, the second batch we can generally know the country to pick the third batch of the approximate logical order, as shown in figure:(source: feng yun medicine)the first two batches of three rounds of quotation comprehensive situation combing, as shown in the figure:(source: Shanghai collection official website feng yun-powder finishing)about the timeline to pay special attention to the quote time, which is linked with the approval time, the second batch of time as long as before the quotation to get the document can participate, can participate in and quote time is closely relatedquestion: Is this time particularly urgent?: Normal time progress, the second batch is Issued on November 28, 2019 volume documents, December 10, the middle interval of 12 daysthis time is June 22, 2020 issued volume documents, july 3, 2020, from the time point of view, there is little changereporting volume and supervisionincrease clinical supervision(source: Ningxia Hunan reporting documentfeng drug talk finishing) concern1: health insurance fixed-point non-public hospitals, retail pharmacies are still in voluntary filing, which is related to the follow-up market development 2: the mechanism of savings incentives----- such as the report inge of 1 million tablets, requiring the completion of 60%, if, the hospital completed more than 600,000 tablets, not more than 1 million tablets, the savings part of the award hospital half, more than 1 million cancelled incentives logically , binding this report according to this article may be higher than the ratio (actual use) of the previous two times There are four reasons for : 1, actual /reporting 0.35: the volume is basically about one-third of the actual usage 2, the amount of discount: the actual amount of the winning amount of 0.35% (50%/60%/70%/80%) 3, the final procurement / the selection of 2: the selected varieties do not do work, in the number of selected on the basis of which can easily double 4, the remaining 25%: the conventional non-selection has about one-third of the use, this time to encourage reasonable declaration, encourage reuse catalogue and number of households related to the competitive pattern third batch: 56 products, 86 specifications, 213 general product regulations involved: 147 domestic enterprises, 27 foreign enterprises (including duplicate varieties of manufacturers) (Source: Ningxia Hunan Reporting documents wind medicine talk finishing) competition and quotation pattern (as of 2020/06/23): there is no finishing specific manufacturers, corresponding rules, because the national harvest is according to a single variety of manufacturers to calculate the finalist ratio, not according to specific specifications to quote so, just count the quantity! (source of information: Fengyun medicine talk finishing) the second batch of domestic capital and foreign enterprises marked intention: (source: Shanghai collection official website Fengyun drug talk finishing) this shortlist rules have not been released, so wait on Wednesday good, do not have to read too much, wait! The big probability follows the second batch of rules, and the details section may be fine-tuned catalog more accurate
dosage form clear
this round in the specification description of a more precise, some like the 2019 Health Care Catalog, in the controversial or confusing specifications made clear Monrust identified the mouth collapse tablets as a group, the particles were a group; ibuprofen particles, did not write oral changas form, because there are tablets also over; amoxicillin is also particles, the second batch is written amosilin oral often-release dosage form increased the dosage form of the eye drops, increased the dosage form of the oral solution, increased the personalized demand of sedinafine and dapositin, the injection matched only ampichimino and just enough three Parisib sodium was not included clear dosage form distinction significance: for research and development projects, the choice of which dosage form is very important, if it is a combination of dosage form then single dosage type project selection will be carefully considered particles, mouth collapse, slow release is currently a single column, tablets, dispersed tablets, capsules are a group break the routine
those rumors there are a lot of rumors about the national pick, it's really similar 1, once a year: the future of the country to adopt the normal, when the introduction of medical insurance payment standards, basically a close 2, 25 varieties: at the end of 2019 there was a mention of this matter, this time 56 varieties, breaking this rumor 3, catalog: catalog did not come out of all kinds of information flying, even nitric acid isosoris, ibuprofen injection sie, both have been evaluated into, pure data party look forward to the June 24th Shanghai meeting of the specific details of the introduction! .